Okamoto M, Rosenberg H C, Boisse N R
J Pharmacol Exp Ther. 1975 Mar;192(3):555-69.
The method of "maximally tolerable" dosing technique for establishing a reproducible state of barbiturate dependence in cats was used for the study. The development of tolerance in animals treated by this method has been quantitatively assessed. Sodium pentobarbital was administered morning and evening for 35 days via a plastic tube implanted into the stomach through the abdominal wall. A range of neurological signs of intoxication was scored before and after each dose and during the day at certain preset intervals. Based on the scoring of neurological impairment, each cat was given the maximally tolerable anesthetic dose of sodium pentobarbital. All of the animals treated by this method exhibited severe withdrawal signs upon abrupt withdrawal of the drug. For each cat, blood pentobarbital concentrations were determined every day before and 1 to 11/4 hours after the morning dose. Also, a complete blood pentobarbital elimination study was made on days 1, 7, 14, 21, 28 and 35 of the regimen. These results distinguished between dispositional and functional tolerance. The dispositional tolerance developed maximally within a week and was maintained at that level as long as the treatment was continued. The functional tolerance, on the other hand, developed more gradually and progressed with continued treatment.
本研究采用“最大耐受”给药技术在猫身上建立可重复的巴比妥类药物依赖状态。已对用该方法治疗的动物的耐受性发展进行了定量评估。戊巴比妥钠通过经腹壁植入胃内的塑料管早晚给药35天。在每次给药前、给药后以及一天中按特定预设间隔对一系列中毒神经体征进行评分。根据神经损伤评分,给每只猫给予戊巴比妥钠的最大耐受麻醉剂量。用该方法治疗的所有动物在突然停药时均表现出严重的戒断症状。对每只猫,每天在早晨给药前以及给药后1至1又1/4小时测定血戊巴比妥浓度。此外,在给药方案的第1、7、14、21、28和35天进行了全血戊巴比妥消除研究。这些结果区分了代谢耐受性和功能耐受性。代谢耐受性在一周内达到最大,并在持续治疗期间维持在该水平。另一方面,功能耐受性发展较为缓慢,并随着持续治疗而进展。